Skip to content
2000
Volume 21, Issue 2
  • ISSN: 1573-4021
  • E-ISSN: 1875-6506

Abstract

Introduction

According to current clinical practice guidelines, Ambulatory Blood Pressure Measurement (ABPM) is recommended to confirm diagnoses of hypertension. It remains unclear as to which method is superior in predicting mortality outcomes.

Methods

Prospective observational studies, comparing ABPM with Clinical Blood Pressure Measurements (CBPM), were included with outcomes of the study being all-cause and cardiovascular mortality.

Results

Nine studies with a total of 23,140 participants were included. Each 10-mmHg increase in 24-hour mean systolic blood pressure (SBP) was linked to a higher risk of all-cause mortality (HR: 1.13, 95% CI: 1.09–1.18), while Clinic Blood Pressure Measurement (CBPM) was not a significant predictor (HR: 1.02, 95% CI: 0.90–1.13). Nighttime SBP increases of 10 mmHg were associated with a higher all-cause mortality risk than daytime SBP (HR: 1.16, 95% CI: 1.11–1.21 HR: 1.08, 95% CI: 1.05–1.12). For cardiovascular mortality, a 10 mmHg increase in SBP yielded an HR of 1.21 (95% CI: 1.16–1.27) for 24-hour ABPM compared to 1.08 (95% CI: 1.04–1.11) for CBPM. Similarly, for a 5 mmHg increase in Diastolic Blood Pressure (DBP), the HR was 1.14 (95% CI: 1.07–1.20) for 24 hour ABPM 1.04 (95% CI: 1.01–1.07) for clinical DBP, highlighting 24-hour monitoring as a stronger predictor for cardiovascular mortality.

Conclusion

The findings of this study support the superiority of ABPM measurements in predicting both all-cause and cardiovascular mortality.

Loading

Article metrics loading...

/content/journals/chyr/10.2174/0115734021337639250203175636
2025-02-11
2025-09-25
Loading full text...

Full text loading...

References

  1. BoatengE.B. AmpofoA.G. A glimpse into the future: Modelling global prevalence of hypertension.BMC Public Health2023231190610.1186/s12889‑023‑16662‑z 37789258
    [Google Scholar]
  2. StanawayJ.D. AfshinA. GakidouE. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: A systematic analysis for the global burden of disease study 2017.Lancet2018392101591923199410.1016/S0140‑6736(18)32225‑6 30496105
    [Google Scholar]
  3. ZhouB. Carrillo-LarcoR.M. DanaeiG. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants.Lancet20213981030495798010.1016/S0140‑6736(21)01330‑1 34450083
    [Google Scholar]
  4. GulecS. Early diagnosis saves lives: Focus on patients with hypertension.Kidney Int. Suppl.20133433233410.1038/kisup.2013.69 25019014
    [Google Scholar]
  5. UngerT. BorghiC. CharcharF. 2020 international society of hypertension global hypertension practice guidelines.Hypertension20207561334135710.1161/HYPERTENSIONAHA.120.15026 32370572
    [Google Scholar]
  6. DrawzP.E. AbdallaM. RahmanM. Blood pressure measurement: Clinic, home, ambulatory, and beyond.Am. J. Kidney Dis.201260344946210.1053/j.ajkd.2012.01.026 22521624
    [Google Scholar]
  7. GreenlandP. Effective use of ambulatory blood pressure monitoring.JAMA2019322542042110.1001/jama.2019.10123 31386117
    [Google Scholar]
  8. ParatiG. OchoaJ.E. BiloG. Moving beyond office blood pressure to achieve a personalized and more precise hypertension management.Hypertension2017703e20e3110.1161/HYPERTENSIONAHA.117.08250 28760937
    [Google Scholar]
  9. ShimboD. AbdallaM. FalzonL. TownsendR.R. MuntnerP. Role of ambulatory and home blood pressure monitoring in clinical practice.Ann. Intern. Med.2015163969170010.7326/M15‑1270 26457954
    [Google Scholar]
  10. DesaiR. DietrichE.A. ParkH. SmithS.M. Out-of-pocket payment for ambulatory blood pressure monitoring among commercially insured in the United States.Am. J. Hypertens.20203311999100210.1093/ajh/hpaa120 32930343
    [Google Scholar]
  11. HuttonB. SalantiG. CaldwellD.M. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations.Ann. Intern. Med.20151621177778410.7326/M14‑2385 26030634
    [Google Scholar]
  12. LewingtonS. ClarkeR. QizilbashN. PetoR. CollinsR. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies.Lancet200236093491903191310.1016/S0140‑6736(02)11911‑8 12493255
    [Google Scholar]
  13. WellsG.A. WellsG. SheaB. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.2000Available from: https://www.semanticscholar.org/paper/The-Newcastle-Ottawa-Scale-(NOS)-for-Assessing-the-Wells-Wells/c293fb316b6176154c3fdbb8340a107d9c8c82bf
  14. DawesM.G. CoatsA.J. JuszczakE. Daytime ambulatory systolic blood pressure is more effective at predicting mortality than clinic blood pressure.Blood Press. Monit.200611311111810.1097/01.mbp.0000209086.32493.bd 16702819
    [Google Scholar]
  15. DolanE. StantonA. ThijsL. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study.Hypertension200546115616110.1161/01.HYP.0000170138.56903.7a 15939805
    [Google Scholar]
  16. GąsowskiJ. LiY. KuznetsovaT. Is “usual” blood pressure a proxy for 24-h ambulatory blood pressure in predicting cardiovascular outcomes?Am. J. Hypertens.2008219994100010.1038/ajh.2008.231 18600212
    [Google Scholar]
  17. HansenT.W. JeppesenJ. RasmussenS. IbsenH. Torp-PedersenC. Ambulatory blood pressure and mortality: A population-based study.Hypertension200545449950410.1161/01.HYP.0000160402.39597.3b 15753229
    [Google Scholar]
  18. KikuyaM. OhkuboT. AsayamaK. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: The Ohasama study.Hypertension200545224024510.1161/01.HYP.0000152079.04553.2c 15596571
    [Google Scholar]
  19. OhkuboT. KikuyaM. MetokiH. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.J. Am. Coll. Cardiol.200546350851510.1016/j.jacc.2005.03.070 16053966
    [Google Scholar]
  20. StaessenJ.A. ThijsL. FagardR. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension.JAMA1999282653954610.1001/jama.282.6.539 10450715
    [Google Scholar]
  21. VerdecchiaP. SchillaciG. BorgioniC. CiucciA. PedeS. PorcellatiC. Ambulatory pulse pressure: A potent predictor of total cardiovascular risk in hypertension.Hypertension199832698398810.1161/01.HYP.32.6.983 9856961
    [Google Scholar]
  22. WingL.M.H. ChowdhuryE.K. ReidC.M. BeilinL.J. BrownM.A. Night-time ambulatory blood pressure is the best pretreatment blood pressure predictor of 11-year mortality in treated older hypertensives.Blood Press. Monit.201823523724310.1097/MBP.0000000000000331 29864033
    [Google Scholar]
  23. VerdecchiaP. ReboldiG. PorcellatiC. Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects.J. Am. Coll. Cardiol.200239587888510.1016/S0735‑1097(01)01827‑7 11869856
    [Google Scholar]
  24. ImaiY. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: Follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study.Circulation19961111417771783
    [Google Scholar]
  25. OhkuboT. ImaiY. TsujiI. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements.J. Hypertens.199715435736410.1097/00004872‑199715040‑00006 9211170
    [Google Scholar]
  26. KhattarR.S. SeniorR. LahiriA. Cardiovascular outcome in white-coat versus sustained mild hypertension: A 10-year follow-up study.Circulation199898181892189710.1161/01.CIR.98.18.1892 9799210
    [Google Scholar]
  27. RedonJ. CamposC. NarcisoM.L. RodicioJ.L. PascualJ.M. RuilopeL.M. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: A prospective study.Hypertension199831271271810.1161/01.HYP.31.2.712 9461245
    [Google Scholar]
  28. ZweikerR. EberB. SchumacherM. ToplakH. KleinW. “Non-dipping” related to cardiovascular events in essential hypertensive patients.Acta Med. Austriaca19942138689 7701925
    [Google Scholar]
  29. PiperM.A. EvansC.V. BurdaB.U. MargolisK.L. O’ConnorE. WhitlockE.P. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: A systematic review for the U.S. preventive services task force.Ann. Intern. Med.2015162319220410.7326/M14‑1539 25531400
    [Google Scholar]
  30. VerdecchiaP. Prognostic value of ambulatory blood pressure: Current evidence and clinical implications.Hypertension200035384485110.1161/01.HYP.35.3.844 10720605
    [Google Scholar]
  31. PickeringT.G. DavidsonK. GerinW. SchwartzJ.E. Masked hypertension.Am Heart Assoc.2002795796
    [Google Scholar]
  32. WheltonP.K. CareyR.M. AronowW.S. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Hypertension2018716e13e115 29133356
    [Google Scholar]
  33. GorostidiM. VinyolesE. BanegasJ.R. de la SierraA. Prevalence of white-coat and masked hypertension in national and international registries.Hypertens. Res.20153811710.1038/hr.2014.149 25319601
    [Google Scholar]
  34. RoushGC FagardRH SallesGF Prognostic impact of sexambulatory blood pressure interactions in 10 cohorts of 17 312 patients diagnosed with hypertension: systematic review and metaanalysis. J Hypertens.2015Feb 3322122010.1097/HJH.0000000000000435. 25479023
    [Google Scholar]
  35. ConenD. BambergF. Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: A systematic review and meta-analysis.J. Hypertens.20082671290129910.1097/HJH.0b013e3282f97854 18550999
    [Google Scholar]
  36. GreenbergJ.A. Removing confounders from the relationship between mortality risk and systolic blood pressure at low and moderately increased systolic blood pressure.J. Hypertens.2003211495610.1097/00004872‑200301000‑00013 12544435
    [Google Scholar]
  37. ShimboD. AbdallaM. FalzonL. TownsendR.R. MuntnerP. Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality out-comes: A systematic review.J. Am. Soc. Hypertens.201610322423410.1016/j.jash.2015.12.013
    [Google Scholar]
  38. ManciaG. FagardR. NarkiewiczK. 2013 ESH/ESC Guidelines for the management of arterial hypertension.Eur. Heart J.201334282159221910.1093/eurheartj/eht151 23771844
    [Google Scholar]
  39. McCormackT. BoffaR.J. JonesN.R. CarvilleS. McManusR.J. The 2018 ESC/ESH hypertension guideline and the 2019 NICE hypertension guideline, how and why they differ.Eur. Heart J.201940423456345810.1093/eurheartj/ehz681 31589745
    [Google Scholar]
  40. GabbG.M. MangoniA.A. AndersonC.S. Guideline for the diagnosis and management of hypertension in adults — 2016.Med. J. Aust.20162052858910.5694/mja16.00526 27456450
    [Google Scholar]
  41. ShimamotoK. AndoK. FujitaT. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2014).Hypertens. Res.201437425339010.1038/hr.2014.20 24705419
    [Google Scholar]
  42. ConenD. RidkerP.M. BuringJ.E. GlynnR.J. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: Prospective cohort study.BMJ2007335761743210.1136/bmj.39269.672188.AE 17704543
    [Google Scholar]
  43. Björklund K, Lind L, Zethelius B, Andrén B, Lithell H. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men.Circulation200310791297130210.1161/01.CIR.0000054622.45012.12 12628951
    [Google Scholar]
  44. ClementD.L. De BuyzereM.L. De BacquerD.A. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension.N. Engl. J. Med.2003348242407241510.1056/NEJMoa022273 12802026
    [Google Scholar]
  45. OhkuboT. HozawaA. NagaieK. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population.J. Hypertens.200018784785410.1097/00004872‑200018070‑00005 10930181
    [Google Scholar]
  46. SuzukiY. KuwajimaI. AonoT. Prognostic value of nighttime blood pressure in the elderly: A prospective study of 24-hour blood pressure.Hypertens. Res.200023432333010.1291/hypres.23.323 10912768
    [Google Scholar]
  47. AungK. HtayT. Relationship between outpatient clinic and ambulatory blood pressure measurements and mortality.Curr. Cardiol. Rep.20192152810.1007/s11886‑019‑1114‑z 30880364
    [Google Scholar]
  48. BoggiaJ. LiY. ThijsL. Prognostic accuracy of day versus night ambulatory blood pressure: A cohort study.Lancet200737095941219122910.1016/S0140‑6736(07)61538‑4 17920917
    [Google Scholar]
  49. StaplinN de la SierraA RuilopeLM Relationship between clinic and ambulatory blood pressure and mortality: An observational cohort study in 59 124 patients. Lancet.2023401 (10393)2041205010.1016/S0140‑6736(23)00733‑X. 37156250
  50. VischerA.S. BurkardT. Principles of blood pressure measurement - Current techniques, office vs ambulatory blood pressure measurement.Adv. Exp. Med. Biol.20179568596
    [Google Scholar]
  51. SegaR FacchettiR BombelliM Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: Follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation2005111(14)17778310.1161/01.CIR.0000160923.04524.5B. 15809377
  52. ManciaG. FacchettiR. BombelliM. GrassiG. SegaR. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure.Hypertension200647584685310.1161/01.HYP.0000215363.69793.bb 16567588
    [Google Scholar]
  53. HansenT.W. JeppesenJ. RasmussenS. IbsenH. Torp-PedersenC. Ambulatory blood pressure monitoring and risk of cardiovascular disease: A population based study.Am. J. Hypertens.200619324325010.1016/j.amjhyper.2005.09.018 16500508
    [Google Scholar]
  54. DolanE. StaessenJ.A. O’BrienE. Data from the Dublin outcome study.Blood Press. Monit.200712640140310.1097/MBP.0b013e328244df74 18277321
    [Google Scholar]
  55. MuxfeldtE.S. CardosoC.R.L. SallesG.F. Prognostic value of nocturnal blood pressure reduction in resistant hypertension.Arch. Intern. Med.2009169987488010.1001/archinternmed.2009.68 19433699
    [Google Scholar]
  56. SallesG.F. CardosoC.R. FonsecaL.L. FiszmanR. MuxfeldtE.S. Prognostic significance of baseline heart rate and its interaction with beta-blocker use in resistant hypertension: A cohort study.Am. J. of Hypertens.201326221822610.1093/ajh/hps004 23382406
    [Google Scholar]
  57. AndreadisE.A. GeladariC.V. AngelopoulosE.T. KolyvasG.N. PapademetriouV. Morning surge and peak morning ambulatory blood pressure versus automated office blood pressure in predicting cardiovascular disease.High Blood Press. Cardiovasc. Prev.201926320921510.1007/s40292‑019‑00315‑7 30989620
    [Google Scholar]
  58. CardosoC.R.L. SallesG.C. SallesG.F. Prognostic importance of on-treatment clinic and ambulatory blood pressures in resistant hypertension: A Cohort Study.Hypertension20207551184119410.1161/HYPERTENSIONAHA.120.14782 32200673
    [Google Scholar]
/content/journals/chyr/10.2174/0115734021337639250203175636
Loading
/content/journals/chyr/10.2174/0115734021337639250203175636
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test